top of page

Project Overview

This project explores gene expression differences between healthy bladder tissue and superficial (early-stage) bladder cancer. Using bioinformatics tools like R, CIBERSORTx, and gene enrichment analysis, our team identified key immune pathways and cell types involved in tumor development and recurrence.

Project

Tools & Techniques: R, T-Tests, Gene Ontology Enrichment, CIBERSORTx, Graphing in R, Data Cleaning & Analysis

Tech Stack

This is the space to introduce the Services section. Briefly describe the types of services offered and highlight any special benefits or features.

Service Name

This is the space to introduce the Services section. Briefly describe the types of services offered and highlight any special benefits or features.

Service Name

Clinical Impact

Early detection biomarkers like HLA-DRA and DOCK10 could support proactive screening, especially in high-risk groups (e.g., cystic fibrosis patients)

Support emerging treatments that restore immune balance

Key Takeaways

Screenshot 2025-04-16 at 10.49.28 PM.png

Key Findings

Increased Tregs and dendritic cells contribute to immune evasion

Suppression of CD4/CD8 T cells weakens immune memory and tumor response

Identified drug targets: PALBOCICLIB (CDK4/6 inhibitor), AMG900 (Aurora kinase inhibitor)

Data Overview

1836 samples across 233 patients

Analyzed 43,000+ genes with statistical testing (T-tests on 803 genes)

Core Analysis

Differential gene expression between normal tissue and primary BC superficial tumors

Enrichment analysis revealed immune suppression and chronic inflammation pathways

CIBERSORTx used to estimate immune cell types in the tumor microenvironment

Bladder Cancer Gene Expression Analysis

Cystic Fibrosis

HLA-DRA is involved in critical processes linked to cystic fibrosis 

 

Cancer Risk

Individuals with CF are 5-10x more likely to develop colon cancer.

Highlights the need for proactive screening in CF patients.

 

Corneal Dystrophy:

 

A condition characterized by recurring structural abnormalities in the cornea.

Known for its recurring nature

Both conditions involve incomplete resolution of the initial damage, leading to a cycle of recurrence.

bottom of page